Sign Up Today and Learn More About GT Medical Technologies Stock
Invest in or calculate the value of your shares in GT Medical Technologies or other pre-IPO companies through EquityZen's platform.
GT Medical Technologies Stock (GTMT)
GT Medical Technologies provides surgically targeted radiation therapy to individuals with operable brain tumors.
About GT Medical Technologies Stock
Founded
2017
Headquarters
Tempe, AZ, US
Industries
Consumer Goods, Software, Artificial Intelligence
GT Medical Technologies Press Mentions
Stay in the know about the latest news on GT Medical Technologies
Prospective Multicenter Registry Study Reports High Local Tumor Control Following Resection with GammaTile® in Newly Diagnosed Brain Metastases
prnewswire • Feb 26, 2026
GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
prnewswire • Jan 16, 2026
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
prnewswire • Jan 16, 2026
GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
prnewswire • Oct 31, 2025
Journal of Neuro-Oncology Publishes New Data Reinforcing GammaTile® Efficacy in Treating Recurrent Brain Metastases
prnewswire • Sep 12, 2025
GT Medical Technologies Management
Leadership team at GT Medical Technologies
Vice President Marketing
Jane Steen
Vice President Clinical Affairs
Lisa Misell
Join now and verify your accreditation status to gain access to:
- GT Medical Technologies Current Valuation
- GT Medical Technologies Stock Price
- GT Medical Technologies Management
- Available deals in GT Medical Technologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- GT Medical Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
- GT Medical Technologies Revenue and Financials
- GT Medical Technologies Highlights
- GT Medical Technologies Business Model
- GT Medical Technologies Risk Factors
- GT Medical Technologies Research Report from SACRA Research
Trading GT Medical Technologies Stock
How to invest in GT Medical Technologies stock?
Accredited investors can buy pre-IPO stock in companies like GT Medical Technologies through EquityZen funds. These investments are made available by existing GT Medical Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell GT Medical Technologies stock?
Shareholders can sell their GT Medical Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
